Status: current, Defined. Date: 31-Dec 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2166981000168112 | Targin 20/10 mg (naloxone hydrochloride 10 mg + oxycodone hydrochloride 20 mg) modified release tablet, 60 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2166991000168110 | Targin 20/10 mg modified release tablet, 60, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Targin 20/10 mg modified release tablet, 60, blister pack | Is a | Targin 20/10 mg modified release tablet, 60 | true | Inferred relationship | Some | ||
| Targin 20/10 mg modified release tablet, 60, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Targin 20/10 mg modified release tablet, 60, blister pack | has TPUU | Targin 20/10 mg modified release tablet | true | Inferred relationship | Some | 1 | |
| Targin 20/10 mg modified release tablet, 60, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Targin 20/10 mg modified release tablet, 60, blister pack | has TP | Targin 20/10 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Schedule 8 medications reference set
Containered trade product pack reference set
FHIR